Page last updated: 2024-10-20

pyridoxine and Marchiafava-Bignami Disease

pyridoxine has been researched along with Marchiafava-Bignami Disease in 1 studies

4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).

Marchiafava-Bignami Disease: A neurodegenerative condition that is characterized by demyelination or necrosis of the CORPUS CALLOSUM. Symptoms include DEPRESSION; PARANOIA; DEMENTIA; SEIZURES; and ATAXIA which can progress to COMA and death in a few months. Marchiafava-Bignami syndrome is seen often in alcoholics but has been found in non-alcoholics as well.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aggunlu, L1
Oner, Y1
Kocer, B1
Akpek, S1

Other Studies

1 other study available for pyridoxine and Marchiafava-Bignami Disease

ArticleYear
The value of diffusion-weighted imaging in the diagnosis of Marchiafava-Bignami disease: apropos of a case.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2008, Volume: 18, Issue:2

    Topics: Adult; Diffusion Magnetic Resonance Imaging; Humans; Male; Marchiafava-Bignami Disease; Pyridoxine;

2008